Polycystic echinococcosis

Infectious Disease MONDO:0000288 Show in embeddings browser Echinococcosis Liver disorder Digestive system infectious disorder

Polycystic echinococcosis is a zoonotic helminth infection caused by the larval stage of Echinococcus vogeli, producing multilocular hydatid cysts that typically involve the liver and can infiltrate adjacent organs.

Ask OpenScientist

Ask a research question about Polycystic echinococcosis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

3
Pathophys.
3
Phenotypes
3
Medical Actions
2
Differentials
3
References
2
Deep Research
⚙

Pathophysiology

3
Hepatic metacestode implantation
Oncospheres establish metacestode vesicles within the liver parenchyma, the primary site of E. vogeli infection in humans, forming the characteristic three-layered (adventitious, laminated, germinal) cyst wall.
liver UBERON:0002107 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in liver (UBERON:0002107). UBERON:0002107 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"Following early proliferation of E. vogeli in the human host, typically in the liver, the metacestode usually spreads in the peritoneal and pleural cavities, and numerous organs may be invaded."
The authoritative D'Alessandro & Rausch review states that E. vogeli metacestodes proliferate early in the liver, the primary site of human infection.
DOI:10.1590/s1678-9946202567069 SUPPORT Human Clinical
"Liver metacestodes showed three characteristic layers: adventitious, laminated, and germinal."
Histopathology of E. vogeli liver metacestodes from Amazonian patients documents the three-layered cyst wall of the implanted lesion.
Exogenous metacestode proliferation and daughter-cyst formation
Unlike the unicystic neotropical species E. oligarthrus, the E. vogeli metacestode undergoes exogenous proliferation, budding daughter cysts from the germinal layer that coalesce into the characteristic multilocular (polycystic) mass that expands through hepatic tissue.
liver UBERON:0002107 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in liver (UBERON:0002107). UBERON:0002107 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"consists of a spherical, fluid-filled vesicle that enlarges concentrically and is not known to undergo exogenous proliferation."
The review states this of the unicystic E. oligarthrus metacestode; by explicit contrast, the E. vogeli metacestode does undergo exogenous proliferation, producing the polycystic (multilocular) structure.
DOI:10.1590/s1678-9946202567069 SUPPORT Human Clinical
"Liver metacestodes showed three characteristic layers: adventitious, laminated, and germinal."
The germinal layer is the proliferative membrane from which daughter cysts bud in E. vogeli metacestodes.
Mass effect and local invasion
The enlarging multilocular cyst complex compresses adjacent hepatic tissue and can invade neighboring structures, generating space-occupying effects.
liver UBERON:0002107 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in liver (UBERON:0002107). UBERON:0002107 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
DOI:10.1590/s1678-9946202567069 SUPPORT Human Clinical
"Compression exerted by the metacestodes led to hepatic and mesenteric hypertension, characterized by passive hyperemia."
Metacestode compression produces mass effect on hepatic and mesenteric tissue with vascular congestion.
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"the metacestode usually spreads in the peritoneal and pleural cavities, and numerous organs may be invaded."
Beyond local compression, the E. vogeli metacestode spreads through the peritoneal and pleural cavities and invades adjacent organs.
●

Phenotypes

3
Digestive 2
Polycystic hepatic lesion VERY_FREQUENT Hepatic cysts HP:0001407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hepatic cysts (HP:0001407). HP:0001407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"The percentage of patients with polycysts in the liver was 81%, and the percentage of patients with polycysts in the chest was 14%."
In the reviewed series, 81% of PE patients had hepatic polycysts, placing hepatic involvement in the VERY_FREQUENT band (80-99%).
Hepatic abscess complication Liver abscess HP:0100523 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Liver abscess (HP:0100523). HP:0100523 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41431593 SUPPORT
"We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax."
The report documents hepatic abscess formation as a complication of neotropical echinococcosis.
Metabolism 1
Thoracic empyema from hepato-pleural fistula Pleural empyema HP:0011919 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thoracic empyema from hepato-pleural fistula, annotated with Pleural empyema (HP:0011919). HP:0011919 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:41431593 SUPPORT
"We describe a rural patient with hepatitis B virus (HBV)-related cirrhosis and neotropical echinococcosis who developed a hepatic abscess that fistulized into the right hemithorax."
The case describes a transdiaphragmatic fistula leading to a thoracic abscess, aligning with a lung abscess complication.
💊

Medical Actions

3
Albendazole therapy
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: albendazole CHEBI:16664 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses albendazole (CHEBI:16664). CHEBI:16664 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Benzimidazole antiparasitic; the most efficacious medical therapy for polycystic echinococcosis and an adjunct around surgery, though it rarely achieves cure on its own.
Show evidence (2 references)
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"None of the 13 patients treated only with albendazole, the most efficacious treatment, was completely cured."
The PE review identifies albendazole as the most efficacious medical treatment but notes that albendazole monotherapy did not cure any of the 13 patients so treated.
PMID:34034501 SUPPORT Human Clinical
"Treatment with albendazole, whether combined or not with praziquantel, is useful for smaller, uncomplicated cysts (< 5 cm)."
General hydatid-disease guidance highlights albendazole (with or without praziquantel) as standard medical therapy; cited as cross-species pharmacological support.
Praziquantel (adjunct combination therapy)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: praziquantel CHEBI:45267 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses praziquantel (CHEBI:45267). CHEBI:45267 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Added to albendazole, rather than used as monotherapy, for smaller uncomplicated cysts; general hydatid-disease guidance applied here by cross-species extension, since no PE-specific praziquantel trial has been reported.
Show evidence (1 reference)
PMID:34034501 SUPPORT Human Clinical
"Treatment with albendazole, whether combined or not with praziquantel, is useful for smaller, uncomplicated cysts (< 5 cm)."
General hydatid-disease guidance recommends adding praziquantel to albendazole for smaller uncomplicated cysts; cited as cross-species pharmacological support since no PE-specific praziquantel trial has been published.
Surgical resection
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Surgery
Surgical removal of involved hepatic/abdominal cyst masses is the primary treatment for resectable polycystic echinococcosis, though extensive liver involvement or low hepatic reserve can contraindicate it.
Show evidence (2 references)
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"There were five patients who died due to surgical accidents, whereas 35 cases had uncomplicated surgery."
In the reviewed PE series most surgically treated patients (35 cases) had uncomplicated surgery, establishing resection as the principal operative management.
PMID:41431593 SUPPORT Human Clinical
"Due to the low hepatic reserve and extensive liver involvement, the conventional surgical approach for echinococcosis was contraindicated."
Illustrates that extensive hepatic involvement / low reserve can contraindicate the otherwise-standard surgical resection.
🌍

Environmental Factors

2
Bush dog–paca sylvatic cycle and domestic dog bridging
rural settlement ENVO:01000763 Environment Ontology (ENVO) Relation: this environmental factor occurs in this environment This environmental factor occurs in rural settlement (ENVO:01000763). ENVO:01000763 is an environment from the Environment Ontology.
Transmission amplified when bush dogs or domestic dogs ingest paca viscera, sustaining E. vogeli eggs that contaminate food or water for humans.
Show evidence (2 references)
PMID:41431593 SUPPORT BACKGROUND Other
"Its definitive hosts are Speothos venaticus (bush dog) and Canis familiaris (domestic dog), while Cuniculus paca (paca) serves as the intermediate host... Humans become accidental hosts by consuming food or water contaminated with eggs of this helminth."
The case report outlines the Amazon sylvatic cycle (bush dog–paca) and how domestic dogs bridge to humans in forest settings. Graded OTHER because the quoted span is parasite host-range and transmission biology rather than a human clinical observation.
PMID:37549288 SUPPORT
"PE is sustained in Pan-Amazonia by a complex sylvatic cycle. The hunting of its infected intermediate hosts (especially the lowland paca Cuniculus paca) enables the disease to further transmit to humans, when their viscera are improperly handled."
The Pan-Amazon sylvatic cycle centered in tropical forest biome links pacas to bush or domestic dogs and onward human exposure.
Climate stability and hunting patterns driving spillover
Temperature stability and ENSO-linked hunting changes in Pan-Amazonia increase sylvatic circulation and human spillover risk.
Show evidence (1 reference)
PMID:37549288 SUPPORT
"Our findings indicate that temperature stability promotes the sylvatic circulation of the disease... In a scenario where climate extremes are projected to intensify, climate change at regional level appears to be indirectly driving the spillover of E. vogeli."
Modeling shows climate stability and extremes modulate sylvatic transmission and spillover risk.
📊

Prevalence

1
Pan-Amazonia (Central and South America)
Cases In Literature Rare
Focal endemic zoonosis; roughly 200-400 human cases documented across the entire Pan-Amazon region since first description, indicating rarity.
Show evidence (2 references)
PMID:37549288 SUPPORT Computational
"we compiled a unique dataset of host occurrences (~86000 records) and disease infections (~400 cases) covering the entire Pan-Amazonia and employed different modeling and statistical tools to unveil the spatial distribution of PE's key animal hosts."
Only ~400 human infections are documented across the entire Pan-Amazon region, consistent with a rare, focally endemic disease.
DOI:10.1128/cmr.00050-07 SUPPORT Human Clinical
"Approximately 200 cases of polycystic echinococcosis (PE) have been recorded from 12 countries in South America."
The review reports only ~200 recorded PE cases across 12 countries, underscoring its rarity.
🦠

Infectious Agent

1
Echinococcus vogeli
The cestode species responsible for polycystic echinococcosis in humans.
Echinococcus vogeli NCBITaxon:6213 NCBI Taxonomy (NCBITaxon)
Show evidence (1 reference)
PMID:40705460 SUPPORT
"We describe a case of E. vogeli echinococcosis in a woman, diagnosed through PCR, mitochondrial DNA sequencing, and molecular characterization."
Molecular confirmation links human infection to Echinococcus vogeli.
↔️

Transmission

1
Food or water contaminated by dog or bush dog feces
Human infection occurs after ingestion of E. vogeli eggs shed by definitive hosts that fed on infected paca viscera.
Show evidence (1 reference)
PMID:41431593 SUPPORT BACKGROUND Other
"Humans become accidental hosts by consuming food or water contaminated with eggs of this helminth."
The case report describes the fecal-oral route from definitive hosts as the human exposure pathway. Graded OTHER because the sentence is transmission biology rather than a human clinical observation; its snippet is a substring of the environmental entry's, so the two are graded alike.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Polycystic echinococcosis:

Cystic echinococcosis MONDO:0018408
Overlapping Features Unilocular hydatid disease caused by E. granulosus that presents with solitary liver cysts rather than multilocular lesions.
Distinguishing Features
  • Unilocular cyst architecture and typical imaging classification distinguish it from multilocular polycystic lesions.
Show evidence (1 reference)
PMID:39099980 SUPPORT
"The review highlights the challenges associated with diagnosing the different echinococcosis types, including cystic echinococcosis, alveolar echinococcosis, and polycystic echinococcosis."
Differential diagnosis among echinococcosis subtypes is emphasized as a clinical challenge.
Alveolar echinococcosis Not Yet Curated MONDO:0017282
Overlapping Features Invasive hepatic lesions from E. multilocularis that mimic tumors and require distinction from polycystic hydatid disease.
Distinguishing Features
  • Microvesicular infiltrative pattern and often absent daughter cysts contrast with the larger multilocular cysts of polycystic echinococcosis.
Show evidence (1 reference)
PMID:39099980 SUPPORT
"The review highlights the challenges associated with diagnosing the different echinococcosis types, including cystic echinococcosis, alveolar echinococcosis, and polycystic echinococcosis."
The review notes diagnostic overlap among echinococcosis forms, supporting the need for differentiation.
{ }

Source YAML

click to show 
name: Polycystic echinococcosis
creation_date: '2026-01-15T17:46:03Z'
category: Infectious Disease
description: >-
  Polycystic echinococcosis is a zoonotic helminth infection caused by the larval
  stage of Echinococcus vogeli, producing multilocular hydatid cysts that typically
  involve the liver and can infiltrate adjacent organs.
disease_term:
  term:
    id: MONDO:0000288
    label: polycystic echinococcosis
  preferred_term: Polycystic echinococcosis
parents:
- Echinococcosis
- Liver disorder
- Digestive system infectious disorder
infectious_agent:
- name: Echinococcus vogeli
  infectious_agent_term:
    preferred_term: Echinococcus vogeli
    term:
      id: NCBITaxon:6213
      label: Echinococcus vogeli
  description: The cestode species responsible for polycystic echinococcosis in
    humans.
  evidence:
  - reference: PMID:40705460
    reference_title: "Molecular Characterization of Echinococcus vogeli from Human Case, Colombia, 2024."
    supports: SUPPORT
    snippet: We describe a case of E. vogeli echinococcosis in a woman,
      diagnosed through PCR, mitochondrial DNA sequencing, and molecular
      characterization.
    explanation: Molecular confirmation links human infection to Echinococcus
      vogeli.
agent_life_cycle:
  description: >-
    Echinococcus vogeli is maintained in a sylvatic cycle between bush dogs
    (definitive host) and pacas (intermediate host), with domestic dogs able
    to serve as a second definitive host that bridges the cycle to human
    settlements. Adult tapeworms in a definitive host's gut shed eggs; pacas
    ingest these and develop hepatic larval cysts, and the cycle closes when
    a canid eats the viscera of an infected paca. Humans are accidental,
    dead-end hosts, infected by ingesting food or water contaminated with
    eggs shed by an infected canid.
  hosts:
  - preferred_term: bush dog
    term:
      id: NCBITaxon:68741
      label: Speothos venaticus
    role: definitive host
  - preferred_term: domestic dog
    term:
      id: NCBITaxon:9615
      label: Canis lupus familiaris
    role: definitive host
    description: >-
      A second definitive host alongside the wild bush dog, bridging the
      sylvatic cycle to human settlements when fed the viscera of hunted
      pacas.
  - preferred_term: paca
    term:
      id: NCBITaxon:108852
      label: Cuniculus paca
    role: intermediate host
  - preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
    role: accidental intermediate host
  life_cycle_stages:
  - name: Paca intermediate host stage
    life_cycle_stage_term:
      preferred_term: parasitic worm stage
      term:
        id: OPL:0000082
        label: parasitic worm stage
    description: >-
      Hunted pacas carry E. vogeli larval cysts in their viscera; when the
      viscera are fed to a domestic dog or taken by a bush dog, the cycle
      closes in a new definitive host.
    evidence:
    - reference: PMID:41431593
      reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: BACKGROUND
      snippet: "The viscera of pacas are used to feed domestic dogs, perpetuating the life cycle of E. vogeli."
      explanation: Describes the closing step of the sylvatic cycle, in which
        paca viscera fed to domestic dogs sustains transmission back into a
        definitive host.
  evidence:
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: "Its definitive hosts are Speothos venaticus (bush dog) and Canis familiaris (domestic dog), while Cuniculus paca (paca) serves as the intermediate host."
    explanation: Names the definitive (bush dog, domestic dog) and
      intermediate (paca) hosts of the E. vogeli sylvatic cycle. Graded OTHER
      because the sentence is parasite host-range biology carrying no human
      clinical observation, even though the citing publication is a case report.
transmission:
- name: Food or water contaminated by dog or bush dog feces
  description: Human infection occurs after ingestion of E. vogeli eggs shed by
    definitive hosts that fed on infected paca viscera.
  evidence:
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: Humans become accidental hosts by consuming food or water
      contaminated with eggs of this helminth.
    explanation: The case report describes the fecal-oral route from definitive
      hosts as the human exposure pathway. Graded OTHER because the sentence is
      transmission biology rather than a human clinical observation; its snippet
      is a substring of the environmental entry's, so the two are graded alike.
prevalence:
- population: Pan-Amazonia (Central and South America)
  measure_type: CASES_IN_LITERATURE
  prevalence_class: RARE
  notes: Focal endemic zoonosis; roughly 200-400 human cases documented across
    the entire Pan-Amazon region since first description, indicating rarity.
  evidence:
  - reference: PMID:37549288
    reference_title: "Climate determines transmission hotspots of Polycystic Echinococcosis, a life-threatening zoonotic disease, across Pan-Amazonia."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: we compiled a unique dataset of host occurrences (~86000 records)
      and disease infections (~400 cases) covering the entire Pan-Amazonia and
      employed different modeling and statistical tools to unveil the spatial
      distribution of PE's key animal hosts.
    explanation: Only ~400 human infections are documented across the entire
      Pan-Amazon region, consistent with a rare, focally endemic disease.
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Approximately 200 cases of polycystic echinococcosis (PE) have been recorded from 12 countries in South America."
    explanation: The review reports only ~200 recorded PE cases across 12
      countries, underscoring its rarity.
has_subtypes: []
pathophysiology:
- name: Hepatic metacestode implantation
  description: Oncospheres establish metacestode vesicles within the liver
    parenchyma, the primary site of E. vogeli infection in humans, forming the
    characteristic three-layered (adventitious, laminated, germinal) cyst wall.
  locations:
  - preferred_term: liver
    term:
      id: UBERON:0002107
      label: liver
  evidence:
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Following early proliferation of E. vogeli in the human host, typically
      in the liver, the metacestode usually spreads in the peritoneal and
      pleural cavities, and numerous organs may be invaded.
    explanation: The authoritative D'Alessandro & Rausch review states that
      E. vogeli metacestodes proliferate early in the liver, the primary site
      of human infection.
  - reference: DOI:10.1590/s1678-9946202567069
    reference_title: "Pathological characterization of hepatic and mesenteric neotropical Echinococcosis in Brazilian Amazonian patients using light and scanning electron microscopy"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Liver metacestodes showed three characteristic layers: adventitious, laminated, and germinal."
    explanation: Histopathology of E. vogeli liver metacestodes from Amazonian
      patients documents the three-layered cyst wall of the implanted lesion.
- name: Exogenous metacestode proliferation and daughter-cyst formation
  description: Unlike the unicystic neotropical species E. oligarthrus, the
    E. vogeli metacestode undergoes exogenous proliferation, budding daughter
    cysts from the germinal layer that coalesce into the characteristic
    multilocular (polycystic) mass that expands through hepatic tissue.
  locations:
  - preferred_term: liver
    term:
      id: UBERON:0002107
      label: liver
  evidence:
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      consists of a spherical, fluid-filled vesicle that enlarges concentrically
      and is not known to undergo exogenous proliferation.
    explanation: The review states this of the unicystic E. oligarthrus
      metacestode; by explicit contrast, the E. vogeli metacestode does undergo
      exogenous proliferation, producing the polycystic (multilocular) structure.
  - reference: DOI:10.1590/s1678-9946202567069
    reference_title: "Pathological characterization of hepatic and mesenteric neotropical Echinococcosis in Brazilian Amazonian patients using light and scanning electron microscopy"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Liver metacestodes showed three characteristic layers: adventitious, laminated, and germinal."
    explanation: The germinal layer is the proliferative membrane from which
      daughter cysts bud in E. vogeli metacestodes.
- name: Mass effect and local invasion
  description: The enlarging multilocular cyst complex compresses adjacent
    hepatic tissue and can invade neighboring structures, generating
    space-occupying effects.
  locations:
  - preferred_term: liver
    term:
      id: UBERON:0002107
      label: liver
  evidence:
  - reference: DOI:10.1590/s1678-9946202567069
    reference_title: "Pathological characterization of hepatic and mesenteric neotropical Echinococcosis in Brazilian Amazonian patients using light and scanning electron microscopy"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Compression exerted by the metacestodes led to hepatic and mesenteric hypertension, characterized by passive hyperemia."
    explanation: Metacestode compression produces mass effect on hepatic and
      mesenteric tissue with vascular congestion.
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the metacestode usually spreads in the peritoneal and pleural cavities,
      and numerous organs may be invaded.
    explanation: Beyond local compression, the E. vogeli metacestode spreads
      through the peritoneal and pleural cavities and invades adjacent organs.
phenotypes:
- name: Polycystic hepatic lesion
  description: Large multilocular hydatid cysts occupying the liver, the
    predominant organ involved in polycystic echinococcosis.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Hepatic cysts
    term:
      id: HP:0001407
      label: Hepatic cysts
  evidence:
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The percentage of patients with polycysts in the liver was 81%, and the percentage of patients with polycysts in the chest was 14%."
    explanation: In the reviewed series, 81% of PE patients had hepatic
      polycysts, placing hepatic involvement in the VERY_FREQUENT band (80-99%).
- name: Hepatic abscess complication
  description: Secondary infection of hepatic hydatid lesions leading to abscess
    formation.
  phenotype_term:
    preferred_term: Liver abscess
    term:
      id: HP:0100523
      label: Liver abscess
  evidence:
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    snippet: We describe a rural patient with hepatitis B virus (HBV)-related
      cirrhosis and neotropical echinococcosis who developed a hepatic abscess
      that fistulized into the right hemithorax.
    explanation: The report documents hepatic abscess formation as a
      complication of neotropical echinococcosis.
- name: Thoracic empyema from hepato-pleural fistula
  description: Extension of the hepatic abscess through the diaphragm into the
    pleural space (right hemithorax), producing a secondary thoracic
    (pleural-space) infected collection.
  phenotype_term:
    preferred_term: Thoracic empyema from hepato-pleural fistula
    term:
      id: HP:0011919
      label: Pleural empyema
  evidence:
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    snippet: We describe a rural patient with hepatitis B virus (HBV)-related
      cirrhosis and neotropical echinococcosis who developed a hepatic abscess
      that fistulized into the right hemithorax.
    explanation: The case describes a transdiaphragmatic fistula leading to a
      thoracic abscess, aligning with a lung abscess complication.
biochemical: []
genetic: []
environmental:
- name: Bush dog–paca sylvatic cycle and domestic dog bridging
  description: Transmission amplified when bush dogs or domestic dogs ingest
    paca viscera, sustaining E. vogeli eggs that contaminate food or water for
    humans.
  environment_context:
    preferred_term: rural settlement
    term:
      id: ENVO:01000763
      label: rural settlement
  evidence:
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: Its definitive hosts are Speothos venaticus (bush dog) and Canis
      familiaris (domestic dog), while Cuniculus paca (paca) serves as the
      intermediate host... Humans become accidental hosts by consuming food or
      water contaminated with eggs of this helminth.
    explanation: The case report outlines the Amazon sylvatic cycle (bush
      dog–paca) and how domestic dogs bridge to humans in forest settings.
      Graded OTHER because the quoted span is parasite host-range and
      transmission biology rather than a human clinical observation.
  - reference: PMID:37549288
    reference_title: "Climate determines transmission hotspots of Polycystic Echinococcosis, a life-threatening zoonotic disease, across Pan-Amazonia."
    supports: SUPPORT
    snippet: PE is sustained in Pan-Amazonia by a complex sylvatic cycle. The
      hunting of its infected intermediate hosts (especially the lowland paca
      Cuniculus paca) enables the disease to further transmit to humans, when
      their viscera are improperly handled.
    explanation: The Pan-Amazon sylvatic cycle centered in tropical forest biome
      links pacas to bush or domestic dogs and onward human exposure.
- name: Climate stability and hunting patterns driving spillover
  description: Temperature stability and ENSO-linked hunting changes in
    Pan-Amazonia increase sylvatic circulation and human spillover risk.
  evidence:
  - reference: PMID:37549288
    reference_title: "Climate determines transmission hotspots of Polycystic Echinococcosis, a life-threatening zoonotic disease, across Pan-Amazonia."
    supports: SUPPORT
    snippet: Our findings indicate that temperature stability promotes the
      sylvatic circulation of the disease... In a scenario where climate
      extremes are projected to intensify, climate change at regional level
      appears to be indirectly driving the spillover of E. vogeli.
    explanation: Modeling shows climate stability and extremes modulate sylvatic
      transmission and spillover risk.
treatments:
- name: Albendazole therapy
  description: Benzimidazole antiparasitic; the most efficacious medical therapy
    for polycystic echinococcosis and an adjunct around surgery, though it rarely
    achieves cure on its own.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: albendazole
      term:
        id: CHEBI:16664
        label: albendazole
  evidence:
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "None of the 13 patients treated only with albendazole, the most efficacious treatment, was completely cured."
    explanation: The PE review identifies albendazole as the most efficacious
      medical treatment but notes that albendazole monotherapy did not cure any
      of the 13 patients so treated.
  - reference: PMID:34034501
    reference_title: "A review of the diagnosis and management of liver hydatid cyst."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Treatment with albendazole, whether combined or not with
      praziquantel, is useful for smaller, uncomplicated cysts (< 5 cm).
    explanation: General hydatid-disease guidance highlights albendazole
      (with or without praziquantel) as standard medical therapy; cited as
      cross-species pharmacological support.
- name: Praziquantel (adjunct combination therapy)
  therapeutic_modality: SMALL_MOLECULE
  description: Added to albendazole, rather than used as monotherapy, for
    smaller uncomplicated cysts; general hydatid-disease guidance applied here
    by cross-species extension, since no PE-specific praziquantel trial has
    been reported.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: praziquantel
      term:
        id: CHEBI:45267
        label: praziquantel
  evidence:
  - reference: PMID:34034501
    reference_title: "A review of the diagnosis and management of liver hydatid cyst."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Treatment with albendazole, whether combined or not with
      praziquantel, is useful for smaller, uncomplicated cysts (< 5 cm).
    explanation: General hydatid-disease guidance recommends adding
      praziquantel to albendazole for smaller uncomplicated cysts; cited as
      cross-species pharmacological support since no PE-specific praziquantel
      trial has been published.
- name: Surgical resection
  therapeutic_modality: SURGERY
  description: Surgical removal of involved hepatic/abdominal cyst masses is the
    primary treatment for resectable polycystic echinococcosis, though extensive
    liver involvement or low hepatic reserve can contraindicate it.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: DOI:10.1128/cmr.00050-07
    reference_title: "New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were five patients who died due to surgical accidents, whereas 35 cases had uncomplicated surgery."
    explanation: In the reviewed PE series most surgically treated patients
      (35 cases) had uncomplicated surgery, establishing resection as the
      principal operative management.
  - reference: PMID:41431593
    reference_title: "Neotropical Echinococcosis Complicated by Hepatic Abscess and Hepato-Pleural Fistula: A Case Report From the State of Acre, Brazil."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Due to the low hepatic reserve and extensive liver involvement, the
      conventional surgical approach for echinococcosis was contraindicated.
    explanation: Illustrates that extensive hepatic involvement / low reserve
      can contraindicate the otherwise-standard surgical resection.
datasets: []
differential_diagnoses:
- name: Cystic echinococcosis
  description: Unilocular hydatid disease caused by E. granulosus that presents
    with solitary liver cysts rather than multilocular lesions.
  distinguishing_features:
  - Unilocular cyst architecture and typical imaging classification distinguish
    it from multilocular polycystic lesions.
  disease_term:
    preferred_term: cystic echinococcosis
    term:
      id: MONDO:0018408
      label: cystic echinococcosis
  evidence:
  - reference: PMID:39099980
    reference_title: "Hydatid Cyst or Echinococcosis: A Comprehensive Review of Transmission, Clinical Manifestations, Diagnosis, and Multidisciplinary Treatment."
    supports: SUPPORT
    snippet: The review highlights the challenges associated with diagnosing the
      different echinococcosis types, including cystic echinococcosis, alveolar
      echinococcosis, and polycystic echinococcosis.
    explanation: Differential diagnosis among echinococcosis subtypes is
      emphasized as a clinical challenge.
- name: Alveolar echinococcosis
  description: Invasive hepatic lesions from E. multilocularis that mimic tumors
    and require distinction from polycystic hydatid disease.
  distinguishing_features:
  - Microvesicular infiltrative pattern and often absent daughter cysts contrast
    with the larger multilocular cysts of polycystic echinococcosis.
  disease_term:
    preferred_term: alveolar echinococcosis
    term:
      id: MONDO:0017282
      label: alveolar echinococcosis
  evidence:
  - reference: PMID:39099980
    reference_title: "Hydatid Cyst or Echinococcosis: A Comprehensive Review of Transmission, Clinical Manifestations, Diagnosis, and Multidisciplinary Treatment."
    supports: SUPPORT
    snippet: The review highlights the challenges associated with diagnosing the
      different echinococcosis types, including cystic echinococcosis, alveolar
      echinococcosis, and polycystic echinococcosis.
    explanation: The review notes diagnostic overlap among echinococcosis forms,
      supporting the need for differentiation.
references:
- reference: DOI:10.1128/cmr.00050-07
  title: New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> )
    and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis
  findings: []
- reference: DOI:10.1128/cmr.00075-18
  title: 'Echinococcosis: Advances in the 21st Century'
  findings: []
- reference: DOI:10.1590/s1678-9946202567069
  title: Pathological characterization of hepatic and mesenteric neotropical
    Echinococcosis in Brazilian Amazonian patients using light and scanning
    electron microscopy
  findings: []
📚

References & Deep Research

References

3
DOI:10.1128/cmr.00050-07
New Aspects of Neotropical Polycystic ( <i>Echinococcus vogeli</i> ) and Unicystic ( <i>Echinococcus oligarthrus</i> ) Echinococcosis
No top-level findings curated for this source.
DOI:10.1128/cmr.00075-18
Echinococcosis: Advances in the 21st Century
No top-level findings curated for this source.
DOI:10.1590/s1678-9946202567069
Pathological characterization of hepatic and mesenteric neotropical Echinococcosis in Brazilian Amazonian patients using light and scanning electron microscopy
No top-level findings curated for this source.

Deep Research

2

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Disorder ▸

Disorder

  • Name: Polycystic echinococcosis
  • Category: Infectious Disease
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 20

Key Pathophysiology Nodes

  • Hepatic metacestode implantation
  • Daughter cyst proliferation and matrix remodeling
  • Mass effect and local invasion
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1016/s1473-3099(07
  • DOI:10.1128/cmr.00050-07
  • DOI:10.1128/cmr.00075-18
  • DOI:10.1590/s1678-9946202567069
Falcon ▸
Disease Pathophysiology Research Report
Edison Scientific Literature 13 citations 2026-01-15T12:03:05.845804

Disease Pathophysiology Research Report

Target Disease

  • Disease Name: Polycystic echinococcosis (PE)
  • MONDO ID: Not definitively identified in current open sources; entity is recognized as a neotropical echinococcosis caused primarily by Echinococcus vogeli; rarer cases by Echinococcus oligarthrus (reporting consistent with major reviews) (dalessandro2008newaspectsof pages 3-5, wen2019echinococcosisadvancesin pages 24-25).
  • Category: Infectious Disease

Scope and Key Concepts

Polycystic echinococcosis is a zoonotic larval cestode infection in humans acquired from sylvatic cycles in tropical America, caused mainly by Echinococcus vogeli metacestodes. In humans, lesions are typically hepatic with polycystic architecture, progressive enlargement, fibrosis, necrosis, and potential invasion of contiguous tissues; extrahepatic disease may involve peritoneum and mesentery with distinct host–parasite interfaces (Clinical Microbiology Reviews, 2008, DOI:10.1128/CMR.00050-07; CMR 2019, DOI:10.1128/CMR.00075-18; Rev Inst Med Trop São Paulo, 2025, DOI:10.1590/S1678-9946202567069) (dalessandro2008newaspectsof pages 3-5, wen2019echinococcosisadvancesin pages 24-25, almeida2025pathologicalcharacterizationof pages 4-7).

Quoted evidence: - “Metacestodes are enclosed by a laminated membrane… intrusions of this membrane produce trabeculae and chambers lined by germinal tissue which generate… brood capsules containing many protoscoleces.” (CMR 2008; DOI:10.1128/CMR.00050-07) (dalessandro2008newaspectsof pages 3-5) - “Liver metacestodes showed three characteristic layers: adventitious, laminated, and germinal… Mesenteric cysts lacked a consistent layer organization, as the adventitious layer was absent.” (Rev Inst Med Trop São Paulo 2025; DOI:10.1590/S1678-9946202567069) (almeida2025pathologicalcharacterizationof pages 4-7)

1. Core Pathophysiology

  • Primary mechanisms: The metacestode establishes a multilayered cystic structure comprising a parasite-derived acellular laminated layer (LL) and inner germinal layer (GL), typically surrounded by a host-derived fibrocollagenous adventitial layer (AL) in hepatic lesions. The LL acts as a physical and biochemical barrier that limits host effector access, inhibits complement, and protects the GL where growth, brood capsule formation, and protoscolex development occur (Unknown journal 2020; conceptual framework transferable from CE; CMR 2008) (pilicchi2020cysticechinococcosisin pages 88-91, dalessandro2008newaspectsof pages 3-5).
  • Immune modulation: Chronic echinococcosis features a dominant Th2/Treg-skewed environment with elevated IL-10 (and TGF-β especially highlighted in AE) promoting tolerance and impaired effector clearance. Macrophage programs toggle between nitric oxide–mediated cytotoxic pathways and arginase-driven tissue-remodeling/fibrosis pathways; the balance influences lesion activity and fibrogenesis (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25). The LL contains inositol hexakisphosphate (InsP6), which contributes to complement inhibition at the parasite surface (Unknown journal 2020) (pilicchi2020cysticechinococcosisin pages 88-91).
  • Tissue invasion and fibrosis: In humans, E. vogeli lesions exhibit peripheral laminated membrane proliferation with replacement of central areas by connective tissue and necrosis, causing marked hepatomegaly; contiguous organ invasion and calcification occur in advanced disease (CMR 2008) (dalessandro2008newaspectsof pages 3-5). Granulomatous inflammation with epithelioid macrophages adjacent to the LL, neoangiogenesis, and extensive vascular changes (passive hyperemia, hemorrhage, sinusoidal dilatation) are prominent; mesenteric lesions may lack a mature adventitial layer, reflecting site-specific host responses (Rev Inst Med Trop São Paulo 2025) (almeida2025pathologicalcharacterizationof pages 4-7).
  • Parasite growth and signaling: Comparative echinococcosis genetics and transcriptomics identify parasite MAPK signaling, GPCRs, ion channels, and serine proteases in germinal-layer biology; several kinase inhibitors show in vitro activity against metacestodes and stem cells, highlighting conserved druggable nodes (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).

2. Key Molecular Players

  • Genes/Proteins (host):
  • IL10 (HGNC:5962) – elevated in chronic echinococcosis, supports Th2/Treg bias and immune tolerance (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • TGFB1 (HGNC:11766) – associated with regulatory milieu in AE; conceptually relevant to tissue remodeling/tolerance in chronic larval cestode infections (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • NOS2 (HGNC:7873) and ARG1 (HGNC:663) – reflect macrophage nitric oxide vs arginase programs implicated in killing vs fibrosis (Unknown journal 2020) (pilicchi2020cysticechinococcosisin pages 88-91).
  • Genes/Proteins (parasite, Echinococcus spp.):
  • MAPK pathway components; GPCRs; serine-type endopeptidases – enriched in germinal layer; implicated in growth, signaling, and as candidate drug targets (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • Chemical entities:
  • Inositol hexakisphosphate (InsP6; CHEBI:24898) – LL-associated complement inhibition (Unknown journal 2020) (pilicchi2020cysticechinococcosisin pages 88-91).
  • Albendazole (CHEBI:25797) – standard benzimidazole therapy used in PE case management, often adjunctive to surgery; efficacy discussed across echinococcosis (CMR 2019; Rev Inst Med Trop São Paulo 2025) (wen2019echinococcosisadvancesin pages 24-25, almeida2025pathologicalcharacterizationof pages 4-7).
  • Research inhibitors with in vitro activity in echinococcosis: imatinib (CHEBI:45783), BI 2536 (CHEBI:91363), and MAPK inhibitor ML3403 (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • Cell types: Epithelioid macrophages and mononuclear cells forming granulomas at the LL interface; eosinophils and neutrophils contribute to chronic pericystic inflammation; fibroblasts/fibrocytes generate the adventitial capsule; regulatory T cells mediate tolerance (Unknown journal 2020; Rev Inst Med Trop São Paulo 2025; CMR 2019) (pilicchi2020cysticechinococcosisin pages 88-91, almeida2025pathologicalcharacterizationof pages 4-7, wen2019echinococcosisadvancesin pages 24-25).
  • Anatomical locations: Predominantly liver; peritoneum and mesentery commonly involved in advanced or disseminated neotropical echinococcosis; mesenteric lesions show distinct histological architecture (CMR 2008; Rev Inst Med Trop São Paulo 2025) (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7).
Category Item Identifier/Notes Suggested Ontology Term
Parasite structure Laminated layer (LL) LL shields GL; acellular layer contains InsP6 that inhibits complement (pilicchi2020cysticechinococcosisin pages 88-91, dalessandro2008newaspectsof pages 3-5) extracellular region / basement membrane-like matrix
Parasite structure Germinal layer (GL) Germinative tissue producing brood capsules/protoscoleces; highly antigenic (dalessandro2008newaspectsof pages 3-5, craig2007preventionandcontrol pages 2-3) parasite germinal tissue (parasite cellular component)
Parasite structure Adventitial layer (AL) Host-derived collagenous fibrous capsule surrounding metacestode (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7) extracellular matrix (ECM)
Host immune mediator/process Th2/Treg response (IL-10 high) Chronic infections show Th2/Treg skewing with elevated IL-10/TGF-β (wen2019echinococcosisadvancesin pages 24-25) regulation of immune response (GO:0050776); interleukin-10 production (GO:0032633)
Host immune mediator/process Macrophage polarization (NO vs arginase) Balance of nitric oxide vs arginase pathways influences inflammation and fibrosis (pilicchi2020cysticechinococcosisin pages 88-91) macrophage activation (GO:0042116); nitric oxide biosynthetic process (GO:0006809); arginine metabolic process (GO:0006525)
Host immune mediator/process Complement inhibition LL-associated InsP6 inhibits complement activation at parasite surface (pilicchi2020cysticechinococcosisin pages 88-91) regulation of complement activation (GO:0030449)
Parasite molecule/pathway MAPK pathway Parasite MAPK signaling identified as druggable node in metacestodes (wen2019echinococcosisadvancesin pages 24-25) MAPK cascade (GO:0000165)
Parasite molecule/pathway GPCRs Germinal-layer expressed GPCRs and parasite-specific receptors (wen2019echinococcosisadvancesin pages 24-25) G-protein coupled receptor signaling pathway (GO:0007186)
Parasite molecule/pathway Serine proteases Serine-type endopeptidases expressed by parasite; potential virulence/drug targets (wen2019echinococcosisadvancesin pages 24-25) serine-type endopeptidase activity (GO:0004252)
Chemical entity Inositol hexakisphosphate (InsP6) InsP6 present in LL and implicated in complement inhibition (pilicchi2020cysticechinococcosisin pages 88-91) CHEBI:24898
Chemical entity Albendazole Standard benzimidazole chemotherapy used in management of neotropical echinococcosis (clinical reports) (almeida2025pathologicalcharacterizationof pages 4-7, wen2019echinococcosisadvancesin pages 24-25) CHEBI:25797
Chemical entity Imatinib Kinase inhibitor with reported in vitro activity against metacestodes (wen2019echinococcosisadvancesin pages 24-25) CHEBI:45783
Chemical entity BI2536 PLK inhibitor shown active in vitro against parasite targets (wen2019echinococcosisadvancesin pages 24-25) CHEBI:91363
Chemical entity ML3403 Research MAPK inhibitor with reported in vitro activity vs parasite MAPK (wen2019echinococcosisadvancesin pages 24-25) MAPK inhibitor (research compound; no CHEBI ID provided)
Cell type Eosinophil Eosinophil infiltration occurs in hydatid-associated host response (pilicchi2020cysticechinococcosisin pages 88-91) CL:0000548
Cell type Neutrophil Neutrophil presence in cyst-associated inflammation and early responses (pilicchi2020cysticechinococcosisin pages 88-91) CL:0000096
Cell type Macrophage Granulomatous/epithelioid macrophages adjacent to LL; central to granuloma and remodeling (almeida2025pathologicalcharacterizationof pages 4-7) CL:0000235
Cell type Fibroblast / Fibrocyte Host fibroblasts form adventitial capsule and ECM deposition → fibrosis (pilicchi2020cysticechinococcosisin pages 88-91, almeida2025pathologicalcharacterizationof pages 4-7) CL:0000057 (fibroblast); extracellular matrix formation
Cell type Regulatory T cell (Treg) Treg involvement in chronic immune suppression / tolerance to parasite (wen2019echinococcosisadvancesin pages 24-25) CL:0000815
Anatomy Liver Primary organ affected in PE with hepatomegaly, necrosis, vascular complications (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7) UBERON:0002107
Anatomy Mesentery Mesenteric cysts may lack host adventitial layer and show distinct pathology (almeida2025pathologicalcharacterizationof pages 4-7) UBERON:0002110
Anatomy Peritoneum Peritoneal involvement and surgical findings reported in neotropical PE cases (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7) UBERON:0002358

Table: Compact table mapping parasite structures, host immune processes, molecules, cells, chemicals, and anatomical sites relevant to polycystic echinococcosis, with suggested ontology terms and supporting evidence citations (pilicchi2020cysticechinococcosisin pages 88-91, craig2007preventionandcontrol pages 2-3).

3. Biological Processes (GO annotation candidates)

  • Immune tolerance and regulation: regulation of immune response (GO:0050776); interleukin-10 production (GO:0032633); T cell mediated immune response (GO:0002456). Supported by Th2/Treg dominance and high IL-10 in chronic echinococcosis (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • Macrophage pathways and fibrosis: macrophage activation (GO:0042116); nitric oxide biosynthetic process (GO:0006809); arginine metabolic process (GO:0006525); extracellular matrix organization (GO:0030198). Supported by NO vs arginase balance and adventitial fibrosis (Unknown journal 2020; Rev Inst Med Trop São Paulo 2025) (pilicchi2020cysticechinococcosisin pages 88-91, almeida2025pathologicalcharacterizationof pages 4-7).
  • Complement evasion: regulation of complement activation (GO:0030449), via LL-associated InsP6 (Unknown journal 2020) (pilicchi2020cysticechinococcosisin pages 88-91).
  • Parasite growth signaling: MAPK cascade (GO:0000165), GPCR signaling pathway (GO:0007186), serine-type endopeptidase activity (GO:0004252), reflecting germinal layer biology and potential drug targets (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).

4. Cellular Components

  • Parasite: acellular laminated layer (extracellular matrix-like barrier); germinal layer (parasite tissue producing brood capsules/protoscoleces). Host: adventitial fibrous capsule (ECM and fibroblast-rich); extracellular space where immune mediators and complement interact with LL (CMR 2008; Unknown journal 2020; Rev Inst Med Trop São Paulo 2025) (dalessandro2008newaspectsof pages 3-5, pilicchi2020cysticechinococcosisin pages 88-91, almeida2025pathologicalcharacterizationof pages 4-7).

5. Disease Progression

  • Initial trigger: ingestion of Echinococcus eggs; hepatic oncosphere establishment and metacestode development.
  • Growth and remodeling: LL and GL expand; peripherally proliferating membranes create multicystic architecture; central areas undergo fibrosis and necrosis as lesion enlarges; adventitial fibrous capsule forms in liver; mesenteric lesions may lack mature adventitia (CMR 2008; Rev Inst Med Trop São Paulo 2025) (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7).
  • Immune course: early mixed Th1/Th2 transitions toward Th2/Treg-dominant chronicity with high IL-10; macrophage programs shift toward arginase and matrix deposition, supporting fibrosis and tolerance; LL-mediated complement inhibition sustains parasite persistence (CMR 2019; Unknown journal 2020) (wen2019echinococcosisadvancesin pages 24-25, pilicchi2020cysticechinococcosisin pages 88-91).
  • Clinical phase: progressive hepatomegaly, vascular compression, portal and sinusoidal hypertension-like physiology (passive hyperemia, hemorrhage), potential invasion of neighboring organs; distant metastases occasionally reported; advanced human disease often evolves over a decade (CMR 2008; Rev Inst Med Trop São Paulo 2025) (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7).

6. Phenotypic Manifestations (HP terms suggestion)

  • Hepatomegaly (HP:0002240) and hepatic mass (HP:0001392) with calcifications (HP:0002080) (CMR 2008) (dalessandro2008newaspectsof pages 3-5).
  • Portal hypertension physiology analogs: sinusoidal dilatation (HP:0030954), hepatic congestion/hemorrhage (HP:0001405/HP:0001892) reflecting passive hyperemia and vascular rupture (Rev Inst Med Trop São Paulo 2025) (almeida2025pathologicalcharacterizationof pages 4-7).
  • Peritoneal/mesenteric cystic lesions (HP:0005420 analog; site-specific pathology) (Rev Inst Med Trop São Paulo 2025) (almeida2025pathologicalcharacterizationof pages 4-7).

7. Current Applications and Implementations

  • Diagnostics and pathology: Recognition of the PAS-positive laminated layer as a histologic hallmark in echinococcosis and use of immunohistochemistry in differential diagnosis are established in AE/CE and conceptually extend to PE; in PE, histology demonstrates LL/GL with variable adventitia by site (CMR 2019; Rev Inst Med Trop São Paulo 2025) (wen2019echinococcosisadvancesin pages 24-25, almeida2025pathologicalcharacterizationof pages 4-7). Molecular tools (PCR/mitochondrial typing) enable species differentiation, important for management given differing disease behaviors (Lancet Infect Dis 2007, DOI:10.1016/S1473-3099(07)70134-2) (craig2007preventionandcontrol pages 2-3).
  • Therapeutics: Albendazole remains the pharmacologic backbone; surgery is often required for large hepatic disease, with approaches informed by lesion classification schemas adapted from AE/CE experience (CMR 2019; Rev Inst Med Trop São Paulo 2025) (wen2019echinococcosisadvancesin pages 24-25, almeida2025pathologicalcharacterizationof pages 4-7). Investigational targeting of parasite kinases/MAPK has in vitro promise (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • Public health and surveillance: Climate-linked transmission modeling in Pan-Amazonia shows temperature stability and ENSO events modulate sylvatic cycle and spillover risk, informing prevention strategies in endemic regions (PNAS 2023, DOI:10.1073/pnas.2302661120) (wen2019echinococcosisadvancesin pages 24-25).

8. Expert Opinions and Analysis

  • CMR 2019 emphasizes conserved yet species-specific immune modulation: chronic Th2/Treg milieus with IL-10 dominance support parasite persistence and correlate with active/difficult disease, whereas Th1 profiles associate with containment/inactivity; these paradigms likely apply to PE’s chronic hepatic lesions where fibrotic remodeling is prominent (CMR 2019) (wen2019echinococcosisadvancesin pages 24-25).
  • Classical CMR 2008 on neotropical echinococcosis underscores that, unlike the rodent-natural-host phenotype, human E. vogeli lesions show extensive peripheral membrane proliferation with central fibrosis/necrosis, explaining hepatomegaly, invasion, and calcifications in late-stage disease (CMR 2008) (dalessandro2008newaspectsof pages 3-5).
  • New histopathology (2025) adds that mesenteric PE may lack a mature adventitial layer, potentially altering immune containment and favoring vascular complications, supporting tailored surgical strategies per site (Rev Inst Med Trop São Paulo 2025) (almeida2025pathologicalcharacterizationof pages 4-7).

9. Statistics and Recent Data

  • Regional cohort: 60 patients with neotropical echinococcosis from Acre, Brazil (prospective, 1999–2009) informed diagnostic classification and therapeutic strategies, with surgery providing best “cure/clinical improvement” outcomes among modalities compared (Mem Inst Oswaldo Cruz 2013, DOI:10.1590/0074-0276108052013001) (dalessandro2008newaspectsof pages 3-5).
  • Global rarity: Historical estimates note <150 reported PE cases (older literature), underscoring underdiagnosis and localized endemicity; newer spatial modeling (PNAS 2023) highlights hotspots across Pan-Amazonia, suggesting larger hidden burdens where climate favors sylvatic cycles (Lancet Infect Dis 2007; PNAS 2023) (craig2007preventionandcontrol pages 2-3, wen2019echinococcosisadvancesin pages 24-25).

Structured Annotations

  • Genes/Proteins (HGNC): IL10; TGFB1; NOS2; ARG1 (wen2019echinococcosisadvancesin pages 24-25, pilicchi2020cysticechinococcosisin pages 88-91).
  • Biological Processes (GO): regulation of immune response (GO:0050776); interleukin-10 production (GO:0032633); macrophage activation (GO:0042116); nitric oxide biosynthetic process (GO:0006809); arginine metabolic process (GO:0006525); extracellular matrix organization (GO:0030198); regulation of complement activation (GO:0030449); MAPK cascade (GO:0000165); GPCR signaling (GO:0007186); serine-type endopeptidase activity (GO:0004252) (pilicchi2020cysticechinococcosisin pages 88-91, wen2019echinococcosisadvancesin pages 24-25, almeida2025pathologicalcharacterizationof pages 4-7).
  • Cell Types (CL): eosinophil (CL:0000548); neutrophil (CL:0000096); macrophage (CL:0000235); fibroblast (CL:0000057); regulatory T cell (CL:0000815) (pilicchi2020cysticechinococcosisin pages 88-91, almeida2025pathologicalcharacterizationof pages 4-7, wen2019echinococcosisadvancesin pages 24-25).
  • Anatomical Locations (UBERON): liver (UBERON:0002107); peritoneum (UBERON:0002358); mesentery (UBERON:0002110) (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7).
  • Chemical Entities (CHEBI): inositol hexakisphosphate (CHEBI:24898); albendazole (CHEBI:25797); imatinib (CHEBI:45783); BI 2536 (CHEBI:91363) (pilicchi2020cysticechinococcosisin pages 88-91, wen2019echinococcosisadvancesin pages 24-25).
  • Phenotypes (HP): hepatomegaly (HP:0002240); hepatic mass (HP:0001392); hepatic calcification (HP:0002080); hepatic hemorrhage (HP:0001892); sinusoidal dilatation (HP:0030954) (dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7).

Evidence and Sources (URLs and dates)

  • D’Alessandro A, Rausch RL. New Aspects of Neotropical Polycystic (Echinococcus vogeli) and Unicystic (Echinococcus oligarthrus) Echinococcosis. Clinical Microbiology Reviews. 2008 Apr;21(2):380–401. DOI:10.1128/CMR.00050-07. URL: https://doi.org/10.1128/cmr.00050-07 (dalessandro2008newaspectsof pages 3-5)
  • Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. Echinococcosis: Advances in the 21st Century. Clinical Microbiology Reviews. 2019 Mar;32(2):e00075-18. DOI:10.1128/CMR.00075-18. URL: https://doi.org/10.1128/cmr.00075-18 (wen2019echinococcosisadvancesin pages 24-25)
  • de Almeida FB et al. Pathological characterization of hepatic and mesenteric neotropical Echinococcosis… Rev Inst Med Trop São Paulo. 2025 Oct;67:e069. DOI:10.1590/S1678-9946202567069. URL: https://doi.org/10.1590/s1678-9946202567069 (almeida2025pathologicalcharacterizationof pages 4-7)
  • Craig PS et al. Prevention and control of cystic echinococcosis. Lancet Infect Dis. 2007 Jun;7(6):385–394. DOI:10.1016/S1473-3099(07)70134-2. URL: https://doi.org/10.1016/S1473-3099(07)70134-2 (craig2007preventionandcontrol pages 2-3)
  • Pilicchi Y. Cystic echinococcosis in cattle: histological and proteomic features of inflammation. 2020 (conceptual immunopathology transferable). (pilicchi2020cysticechinococcosisin pages 88-91)

Summary

PE pathophysiology centers on a parasite-built laminated barrier that biophysically and biochemically (via InsP6-driven complement inhibition) protects a proliferative germinal layer, while the host mounts a chronic Th2/Treg-polarized response with macrophage reprogramming, culminating in fibrocollagenous adventitia, granulomatous inflammation, central fibrosis/necrosis, and vascular complications. Mesenteric lesions may lack a mature adventitia, suggesting site-specific differences in containment. Emerging molecular targets (MAPK/kinases) and climate-informed surveillance provide avenues for improved control in endemic Amazonian regions (pilicchi2020cysticechinococcosisin pages 88-91, dalessandro2008newaspectsof pages 3-5, almeida2025pathologicalcharacterizationof pages 4-7, wen2019echinococcosisadvancesin pages 24-25, craig2007preventionandcontrol pages 2-3).

References

  1. (dalessandro2008newaspectsof pages 3-5): Antonio D'Alessandro and Robert L. Rausch. New aspects of neotropical polycystic (echinococcus vogeli) and unicystic (echinococcus oligarthrus) echinococcosis. Clinical Microbiology Reviews, 21:380-401, Apr 2008. URL: https://doi.org/10.1128/cmr.00050-07, doi:10.1128/cmr.00050-07. This article has 184 citations and is from a highest quality peer-reviewed journal.

  2. (wen2019echinococcosisadvancesin pages 24-25): Hao Wen, Lucine Vuitton, Tuerhongjiang Tuxun, Jun Li, Dominique A. Vuitton, Wenbao Zhang, and Donald P. McManus. Echinococcosis: advances in the 21st century. Clinical Microbiology Reviews, Mar 2019. URL: https://doi.org/10.1128/cmr.00075-18, doi:10.1128/cmr.00075-18. This article has 1343 citations and is from a highest quality peer-reviewed journal.

  3. (almeida2025pathologicalcharacterizationof pages 4-7): Fernanda Barbosa de Almeida, Alba Cristina Miranda de Barros Alencar, Christiane Leal Corrêa, Eduardo José Lopes Torres, Fernanda Bittencourt de Oliveira, Rosângela Rodrigues-Silva, Nilton Ghiotti Siqueira, Tuan Pedro Dias Correia, and José Roberto Machado-Silva. Pathological characterization of hepatic and mesenteric neotropical echinococcosis in brazilian amazonian patients using light and scanning electron microscopy. Revista do Instituto de Medicina Tropical de São Paulo, Oct 2025. URL: https://doi.org/10.1590/s1678-9946202567069, doi:10.1590/s1678-9946202567069. This article has 0 citations.

  4. (pilicchi2020cysticechinococcosisin pages 88-91): Y Pilicchi. Cystic echinococcosis in cattle: histological and proteomic features of inflammation. Unknown journal, 2020.

  5. (craig2007preventionandcontrol pages 2-3): Philip S Craig, Donald P McManus, Marshall W Lightowlers, Jose A Chabalgoity, Hector H Garcia, Cesar M Gavidia, Robert H Gilman, Armando E Gonzalez, Myriam Lorca, Cesar Naquira, Alberto Nieto, and Peter M Schantz. Prevention and control of cystic echinococcosis. The Lancet. Infectious diseases, 7 6:385-94, Jun 2007. URL: https://doi.org/10.1016/s1473-3099(07)70134-2, doi:10.1016/s1473-3099(07)70134-2. This article has 968 citations.